Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology based therapies for patients in need. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through an aggressive business development strategy. The position is tasked with the Leadership of R&D Strategy and Operations to accelerate treatments to patients in a commercial setting and enhance R&D pipeline efficiency, with key responsibilities:• Institution of Program Management/Leadership best practices• Leadership of R&D Governance model• Driving effective R&D long range/strategic planning• Growing Alliance partnerships and have Zenas known as “Partner of Choice”• Fully Integrating R&D into Business Development/Due Diligence Processes

Jaya Biosciences is a privately held pre-clinical stage life sciences company developing CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and frontotemporal dementia. Jaya’s platform is based on the groundbreaking discovery that carriers of loss-of-function mutations in genes for lysosomal enzymes have an increased risk of neurodegeneration, including early onset of symptoms. Serving as a consultant, with key activities including:- Strategy/Preparation for interactions with Investors- Lead Executive Committee Operations- Formation/Maintenance of Academic/Industry Partnerships- Establish Company Infrastructure- Portfolio Strategy/Long Range Planning- Lead Program Plan Development and Execution

Board member for Organization focused on providing support services, education, and research that will help patients and caregivers impacted by Parkinson’s disease live life to the fullest.

Leader of emerging Portfolio and Alliance Management Organization focused on delivering uniQure’s innovative therapies with potentially curative results to patients. The role spans the entirety of uniQure’s best in class adeno-associated virus (AAV)-based gene therapy Research and Development Program portfolio. Key experience includes:• Leadership of cross-functional Global Therapeutic Program Teams, responsible for the development and execution of program strategies for both internal and partnered programs across Hemophilia, CNS, CV and Metabolic Therapeutic areas• Implementation of Event Based R&D Pipeline Stage Gate Process and facilitation of Portfolio Leadership Team decision-making, prioritization and strategic planning• Driving Enterprise/Infrastructure development to support maturing small pharma organization including Resource Management and Mfg/Lab/Office space planning• Management alignment of external technology licenses and development efforts to optimally support current and future portfolio of therapeutic programs• Leadership of large pharma partner therapeutic program out-licensing strategy, planning and execution

Leader of a next generation, strategic Project Management organization within the growing Sanofi-Genzyme Oncology Portfolio of Drug Development Projects spanning Early Development through Phase IV. Tapped specifically to help manage a rapidly expanding portfolio and accelerate projects in an increasingly complex and competitive Drug Development environment. Role requires driving Project Management excellence consistently across the portfolio complemented by the introduction of innovative approaches to further optimize Project Schedule/Cost/Outcomes. Organization structured to create an impact at the Project, Portfolio and Enterprise levels.

Led multi-disciplinary (medical, clinical, regulatory, preclinical, basic science, legal, operations and marketing) biologics franchise steering committee in all aspects of developing current (Myozyme™ and Lumizyme™ Enzyme Replacement Therapies) and next generation treatments for a rare genetic neuromuscular disorder, known as Pompe Disease (incidence rate 1:150,000). Role also included oversight of other Rare disease program managers and design and implementation of continuous improvement and change management efforts across the Rare R&D portfolio

Planned, implemented and drove daily operations of the Pompe Disease Registry, a global, confidential clinical database, sponsored by Genzyme, established to benefit the Pompe community through the collection of longitudinal patient data to increase understanding of the Pompe disease natural course and patient outcomes.

Led planning/execution of consulting engagments in the Life Science practice area of worldwide management consultancy. Clients spanned the spectrum of biopharma companies to include Biotech startups all the way through large established Pharmaceutical interests. Key specialties: Drug Development Process Excellence and Pharma Captial Project Management.

Conducted emergency and periodic maintenance, customer technical training and field R&D testing of medical devices in multi-state territory for a $1B global manufacturer of blood component harvesting equipment.

Served aboard the USS Vicksburg (CG 69) with positions as Anti-Submarine Warfare Officer, Boarding Officer, Nuclear Weapons Safety Officer and Anti-Air Warfare officer.